Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 1
2017 1
2018 1
2019 1
2020 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia.
Losson H, Gajulapalli SR, Lernoux M, Lee JY, Mazumder A, Gérard D, Seidel C, Hahn H, Christov C, Dicato M, Kirsch G, Han BW, Schnekenburger M, Diederich M. Losson H, et al. Among authors: hahn h. Pharmacol Res. 2020 Oct;160:105058. doi: 10.1016/j.phrs.2020.105058. Epub 2020 Jun 30. Pharmacol Res. 2020. PMID: 32619722
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells.
Lernoux M, Schnekenburger M, Losson H, Vermeulen K, Hahn H, Gérard D, Lee JY, Mazumder A, Ahamed M, Christov C, Kim DW, Dicato M, Bormans G, Han BW, Diederich M. Lernoux M, et al. Among authors: hahn h. Clin Epigenetics. 2020 May 19;12(1):69. doi: 10.1186/s13148-020-00839-z. Clin Epigenetics. 2020. PMID: 32430012 Free PMC article.
Structural Basis of Inhibition of DCLK1 by Ruxolitinib.
Jang DM, Lim HJ, Hahn H, Lee Y, Kim HK, Kim HS. Jang DM, et al. Among authors: hahn h. Int J Mol Sci. 2021 Aug 6;22(16):8488. doi: 10.3390/ijms22168488. Int J Mol Sci. 2021. PMID: 34445192 Free PMC article.
11 results